Regular exercise could reduce the severity of hangovers
The study suggests that regular exercise may help reduce the severity of…
Immunotherapy yields complete response in stage IV lung cancer
A case report published in Oncoscience discusses a 51-year-old man with stage…
EMA Recommends New Diagnostic Tool for TB
The European Medicines Agency (EMA) has recommended granting marketing authorization for a…
How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to Come
Generative artificial intelligence is increasingly being utilized in the pharmaceutical industry, automating…
Determining reimbursement for new weight-loss treatments will be ‘the biggest challenge in the medicines area, bar none’ – NCPE head
Prof Michael Barry, the clinical director of the National Centre for Pharmacoeconomics,…
enVista Envy trifocal lens offers improved range of vision
At the AAO meeting, Adam K. Muzychuk, MD, FRCSC discussed the defocus…
Alnylam, RSV, Genentech, Amgen, FDA latest
Alnylam Pharmaceuticals CEO discussed the expansion of their heart drug vutrisiran, which…
Alzheimer’s disease may damage the brain in two phases
New research using brain mapping tools suggests that Alzheimer's disease damages the…
Studies reveal unique challenges faced by younger patients with colorectal cancer
Studies presented at the American College of Surgeons Clinical Congress 2024 reveal…
EMA Authorizes Korjuny for Malignant Ascites
Korjuny, a medication approved by the European Medicines Agency, is used for…